Dalfampridine (Ampyra) for Multiple Sclerosis Treatment
Dalfampridine, commonly known as Ampyra, is an oral medication utilized in the treatment of multiple sclerosis (MS). While its precise mechanism of action remains unknown, it is recognized for impeding the movement of potassium between nerve cells. Animal studies have indicated an enhancement in the conduction of nerve signals. The FDA approved Ampyra in December … Read more